CBAV — Clinica Baviera SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual income statement for Clinica Baviera SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	124	123	173	198	225
Cost of Revenue
Gross Profit	110	107	151	173	198
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	106	102	133	157	175
Operating Profit	18.3	20.5	39.4	41.1	50.1
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17.8	20.2	38.9	40.7	49.7
Provision for Income Taxes
Net Income After Taxes	12.9	14.1	27.9	30.1	36.7
Minority Interest
Net Income Before Extraordinary Items
Net Income	12.8	13.9	27.4	29.5	36
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12.8	13.9	27.4	29.5	36
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.786	0.855	1.68	1.85	2.2
Dividends per Share